Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
Martina Severa, Cinthia Farina, Marco Salvetti, Eliana M. Coccia
Abstract
OPINION article Front. Immunol., 18 June 2020Sec. Multiple Sclerosis and Neuroimmunology Volume 11 - 2020 | https://doi.org/10.3389/fimmu.2020.01459
Topics & Concepts
Multiple sclerosisNeuroimmunologyMedicineCoronavirus disease 2019 (COVID-19)Interferon betaImmunologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyImmune systemInternal medicineDiseaseInfectious disease (medical specialty)OutbreakMultiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and Disorders